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Abstract: The aim of this study is to determine the anxiety and fear related to coronavirus disease 2019
(COVID-19) and their associations with travel, tourism and hospitality, in the Portuguese population.
The Coronavirus Anxiety Scale (CAS) and Fear of COVID-19 Scale (FCV-19S) were validated for the
Portuguese population and correlations with issues related to travel, tourism and hospitality were
established. CAS and FCV-19S presented a good adjustment model and solid reliability and validity.
Correlations between CAS and FCV-19S and the perception of the impact of COVID-19 in travel,
tourism and hospitality were found. Participants considered that COVID-19 mainly affected their
holidays and leisure time. However, the strongest correlation established was between total FCV-19S
and emotional fear FCV-19S and the fear of attending hotel facilities. The Portuguese versions of
CAS and FCV-19S are reliable psychological tools to assess anxiety and fear in relation to COVID-19
for the general population. The use of hotel facilities is the most threatening issue related to travel,
tourism and hospitality. The results suggest that hotels should invest in hygiene and safety measures
that allow users to regain confidence in hotel equipment.
Keywords: Coronavirus Anxiety Scale (CAS); Fear of COVID-19 Scale (FCV-19S); travel; tourism; hos-
pitality
1. Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus caus-
ing coronavirus disease 2019 (COVID-19), the disease that was first discovered in 2019
in China [1]. As of December 28th, 2020, there were 80,879,693 people infected with this
virus around the world, and 1,766,787 died from it. In Portugal, 394,573 people were
infected, and 6619 died [2]. Thus, the COVID-19 pandemic is a massive global health
crisis [3]. The most common symptoms at the onset of COVID-19 are fever, cough and
fatigue [4], although other symptoms include headache, hemoptysis, diarrhea, dyspnea
and lymphopenia [5]. Being male, elderly and having comorbidities have been significantly
associated with the risk of death among COVID-19 patients [6].
As a result of the emergence of the COVID-19 outbreak, a socio-economic crisis and
profound psychological distress occurred worldwide [7]. People who became infected
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with the virus developed psychological disorders associated with the general situation
(isolation, loss of income, loneliness) [8] and their particular situation (fear, uncertainty,
anxiety, depression and post-traumatic stress) [9]. People who did not become infected
saw their family and friends get sick, some of whom even died, triggering feelings of
helplessness, anxiety and fear [10,11].
Anxiety and fear about COVID-19 had other implications for people’s daily lives,
namely, concerning travel (for work, leisure or holidays) [12,13] and hospitality [14,15].
According to Zheng, Luo and Ritchie [9], threat severity and susceptibility may cause
“travel fear”, leading to protection motivation and protective travel behaviors, even after
the pandemic outbreak.
Some authors felt the need to develop tools to assess anxiety and fear in the face of
COVID-19. Lee [16] conceived the Coronavirus Anxiety Scale (CAS), a brief mental health
screener that can be used to identify cases of dysfunctional anxiety related to COVID-19.
This scale has already been adapted to the Bangla [17], Korean [18], Turkish [19] and
Polish [20] languages.
Additionally, Ahorsu and colleagues [10] developed the Fear of COVID-19 Scale
(FCV-19S) to identify and early intervene, psychologically, in people with high values
of fear of COVID-19. This scale has been validated in the Bangla [21], Greek [22], Ara-
bic [23], Malay [24], Italian [25], Hebrew [26] and Spanish [27] languages, Spanish language
in Peru [28], Spanish language in Argentina [29], Portuguese language in Brazil [30],
Japanese [31] and Chinese [32] languages and in Eastern Europe [33] and India [34].
This study aims to determine the anxiety and fear related to COVID 19 and its asso-
ciations with travel, tourism and hospitality, in the Portuguese population. To this end,
instruments have been validated for the Portuguese population to assess anxiety and fear
in relation to COVID-19. Then, the validated tools have been associated with questions
related to travel, tour-ism and hospitality. It has been hypothesized that a good model
of adjustment for CAS and FCV-19S would be found for the Portuguese population (H1)
and it has also been hypothesized that high levels of anxiety and fear related to COVID-19
would be positively associated with a greater perception of the pandemic’s impact on
travel, tourism and hospitality (H2).
2. Materials and Methods
2.1. Procedures
Permission was received from the original authors [10,16] to validate the instru-
ments in a Portuguese population. It was then translated from English to Portuguese
using the back-translation technique [35] (Appendix A, Tables A1 and A2; Appendix B,
Tables A3 and A4). After the protocol was conceived, including the sociodemographic
questionnaire, issues related to travel, tourism and hospitality, CAS and FCV-19S, it was
submitted to the ethics committee of the University of Trás-os-Montes and Alto Douro
(UTAD), having been approved in 1 September 2020. It was released to the general popula-
tion through a social network page about the study, with data being collected between 1
October and 15 November 2020. Convenience and snowball samplings were used. Con-
sequently, the sample is not representative of the Portuguese population. All procedures
performed in this study were in accordance with the ethical standards of the institutional
research committee and with the 1964 Helsinki Declaration and its later amendments.
Informed consent, in which the participants were familiarized with the aims of the study
and in which the confidentiality and anonymity of the data were guaranteed, as well as
the strategy to destroy data after being used, preceded the investigation protocol and the
participants only accessed it after giving their consent.
2.2. Instruments
2.2.1. Sociodemographic Questionnaire
This questionnaire included questions related to gender (man vs. woman), age (nu-
merical), education (no university studies vs. university studies) and employment status
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(inactive—unemployed, sick, retired, on medical leave—vs. active—students, employees,
housewives).
2.2.2. Questions Related to Travel, Tourism and Hospitality
Seven questions were designed to assess the participants’ perceptions of the impact
of COVID-19 on travel, tourism and hospitality in times of the COVID-19 pandemic. The
instruction (“On a scale of 0 to 100, please indicate how much the pandemic situation
caused by COVID-19 has . . . ”) proceeded with the items: 1— . . . “changed your leisure
activities”; 2— . . . “changed your vacations”; 3— . . . “prevented you from settling in a
hotel”; 4— . . . “prevented you from traveling by plane”; 5— . . . “prevented you from
traveling by train”; 6— . . . “prevented you from traveling by car”; and 7— . . . “made you
feel fear of attending hotel facilities”.
2.2.3. Coronavirus Anxiety Scale (CAS)
The CAS was developed with the purpose of filling a void in the mental health
response to COVID-19 [16]. According to Lee [16], a brief mental health screener that could
identify probable cases of dysfunctional anxiety and symptom severity associated with
the coronavirus was needed. This is a five-item scale that assesses distinct physiological
reactions of anxiety related to COVID-19, highly reliable as a cluster (α = 0.93) [16].
2.2.4. Fear of COVID-19 Scale (FCV-19S)
According to Ahorsu and colleagues [10], FCV-19S was developed to complement
the clinical efforts in preventing the spread of and treating COVID-19 cases. This is a
seven-item scale, with robust psychometric properties (composite reliability (CR)—0.88;
average variance extracted (AVE)—0.5; internal consistency [Cronbach’s α]—0.82; standard
error of measurement (SEM)—1.89; item separation reliability (SR) from Rasch—0.99;
item separation index (SI) from Rasch—11.45; person separation reliability (PSR) from
Rasch—0.77; and person separation index (PSI) from Rasch—2.82), being reliable and valid
in assessing fear of COVID-19 among the general population and useful in alleviating
COVID-19 fears among individuals.
2.3. Analytical Approach
An internal replicability approach was employed by subjecting one half of the study’s
data to an exploratory factor analysis (EFA) and the other half to confirmatory factor
analysis (CFA) to address the sampling error influences. The EFA was used to identify
representative symptoms of coronavirus anxiety, while the CFA was used to test the
replicability of the EFA results. The second half of the study’s data was also used to perform
a series of multiple group CFAs to determine if the construct of coronavirus anxiety presents
differences across demographic groups. Pearson correlations between questions related to
travel, tourism and hospitality and anxiety and fear towards COVID-19 were performed, as
well as Spearman correlations between anxiety and fear and sociodemographic variables.
Test–retest reliability was calculated using Pearson correlations to assess the CAS and FCV-
19S constructs’ stability and precision across time. According to the guidelines suggested
by Vaz et al. [36], if the p-value is less than 0.05, and the Pearson correlation coefficient
is above 0.7, then researchers have evidence of test–retest reliability. Statistical analyses
were calculated using Statistical Program for Social Sciences SPSS version 27.0 (IBM Corp.,




Two independent samples with the same number of participants were used. As a
whole, the sample consisted of 1122 participants, of whom 725 (64.6%) are women, with a
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mean age of 31.91 years of age (SD = 13.76), with 495 (44.1%) having university studies and
the remaining (n = 627; 55.9%) without.
Concerning professional status, 932 (83.1%) are active and the remaining are inactive.
The EFA sample (n = 561) was not different from the CFA sample (n = 561) in relation to
sociodemographic issues (chi-square tests and Student’s t tests), except for age [t(1111, 613)
= 2.22; p = 0.027; d = 0.13], being that the EFA sample was slightly older (M = 32.82 years
old; SD = 14.32) than the CFA sample (M = 31.00 years old; SD = 13.12).
3.1.1. Exploratory Factor Analysis (EFA) Results: Coronavirus Anxiety Scale (CAS)
Data screening results suggested that the five items were suitable for EFA [37]: no
issues relating to sample size, missing data, nonnormality, multicollinearity or singularity.
The correlation matrices were factorable [Bartlett’s test of sphericity = p < 0.001; Kaiser
Meyer–Olkin (KMO) test = 0.85)], being that Goretzko et al. [38] suggested the following
values, in EFA: factor loading > 0.5; KMO ≥ 0.5; Bartlett’s test of sphericity to assess
the statistical significance < 0.05; percentage of variance in extraction sums of squared
loadings > 50%.
The five items of the CAS were subjected to an EFA with varimax rotation. The
maximum likelihood factor analysis with a cut-off point of 0.40 and the Kaiser’s criterion
of eigenvalues greater than 1 [39] yielded a one-factor solution as the best fit for the data,
accounting for 67.64% of total variance explained. The five items meet the criteria for
psychometrically sound items (Table 1). Structure coefficients ranged from 0.73 to 0.89,
and communality coefficients ranged from 0.53 to 0.79. Correlations between items ranged
from 0.45 to 0.73. These items were reliable as a single dimension (α = 0.85). If any item
was deleted, alpha’s value decreased.
The test–retest agreement was analysed item by item between the first and second
(n = 31) evaluations. The correlations between the first and the second moments were all
over r = 0.70 and the significance was always above p = 0.50.
Table 1. CAS EFA results.
Items Anxiety Symptom LD h2 M SD Skw Krt Min Max
Item 1 Dizziness 0.89 0.53 1.12 0.42 4.94 29.61 1 5
Item 2 Sleep Disturbances 0.89 0.60 1.43 0.74 2.33 6.19 1 5
Item 3 Tonic Immobility 0.82 0.67 1.31 0.62 2.54 7.14 1 5
Item 4 Appetite Loss 0.77 0.79 1.20 0.54 4.19 20.76 1 5
Item 5 Abdominal Distress 0.73 0.79 1.23 0.58 3.64 15.26 1 5
Total CAS 6.29 2.35
Notes: LD = structure coefficients; h2 = extracted communality coefficients; M = mean; SD = standard deviation;
Skw = skewness; Krt = kurtosis; Min = minimum; Max = maximum; CAS = Coronavirus Anxiety Scale.
3.1.2. Confirmatory Factor Analysis (CFA) Results: Coronavirus Anxiety Scale (CAS)
To test the model found in EFA, a CFA was performed. The results supported the EFA
findings (Figure 1). A one-factor model was found [χ2(4) = 7.67, p = 0.11] with an excellent
fit for all of the indices [χ2/df ratio = 1.92; Comparative Fit Index (CFI) = 1.00; Tucker
Lewis Index (TLI) = 0.99; Standardized Root-Mean-Square Residual (SRMR) = 0.02; Root-
Mean-Square Error of Approximation (RMSEA) = 0.04 (0.00, 0.05; 90% Confidence Interval
(CI)); p-value of Close Fit (PCLOSE) = 0.58]. However, to achieve this model, a correlation
between two items’ errors (items 1 and 4) was established. To test if the coronavirus anxiety
construct was measured the same way across genders (women vs. men), multigroup CFAs
were performed. The results demonstrated gender differences, which were evidenced by
the model fit [χ2(8) = 21.90, p = 0.05] [χ2/df ratio = 2.74; CFI = 0.99; TLI = 0.98; SRMR = 0.04;
RMSEA = 0.06 (0.00, 0.06; 90% CI); PCLOSE = 0.33] and a significant increase in the χ2 value
[∆χ2 (4) = 27.79, p < 0.001] between the models. Women (M = 1.32; SD = 0.50) presented
higher levels of anxiety related to COVID-19 than men (M = 1.14; SD = 0.31).
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3.1.3. Exploratory Factor Analysis (EFA) Results: Fear of COVID-19 Scale (FCV-19S)
Data screening results suggested that the seven items were suitable for EFA [37]:
again, no issues relating o ample size, missing data, nonnormality, multicollinearity or
singularity. The correla ion atrices were also f ctorable [Bartlett’s tes of sphe city =
p < 0.001; Kaiser M yer–Olkin (KMO) test = 0.85)].
The seven items of FCV-19S were subjected to an EFA with varimax rotation. The
maximum likelihood factor analysis with a cut-off point of 0.40 and the Kaiser’s criterion
of eigenvalu s greater than 1 [39] yielded a tw -factor s lution as the best fit for th data,
accou ting for 70.72% of total variance explained. The seven items meet the criteria for
psychometrically sound items (Table 2). Structure coefficients ranged from 0.71 to 0.86,
and co munality coefficients ranged from 0.57 to 0.79. Correlations between items ranged
from 0.37 to 0.72. These items were reliable as a single dimension (α = 0.88) (if any item was
deleted, alpha’s value decreased) and as two-factor dimensions (first one α = 0.83; second
one α = 0.82).
The test–retest agreement was analysed item by item between the first and second
(N = 31) evaluations. The correlations between the first and the second moments were all
over r = 0.70 and the significance was always above p = 0.50.
Table 2. FCV-19S EFA results.
Items Fear Items LD1 LD2 h2 M SD Skw Krt Min Max
Item 1 Fear of COVID-19 0.86 0.76 3.16 1.10 −0.23 −0.53 1 5
Item 2 Uncomfortable 0.81 0.71 3.01 1.07 −0.29 −0.56 1 5
Item 3 Clammy hands 0.82 0.70 1.68 0.77 1.30 2.04 1 5
Item 4 Fear of dying 0.71 0.57 2.65 1.18 0.20 −0.81 1 5
Item 5 News anxiety 0.71 0.67 2.77 1.11 −0.04 −0.77 1 5
Item 6 Trouble sleeping 0.86 0.79 1.79 0.88 1.22 1.33 1 5
Item 7 Tachycardia 0.77 0.75 2.03 1.08 0.98 0.23 1 5
Total FCV-19S 17.20 5.69
Factor 1 1, 2, 4, 5 items Emotional fear 2.90 0.91
Factor 2 3, 6, 7 items Cognitive fear 1.84 0.79
Notes: LD = structure coefficients; h2 = extracted communality coefficients; M = mean; SD = standard deviation; Skw = skewness;
Krt = kurtosis; Min = minimum; Max = maximum; FCV-19S = Fear of Covid-19 Scale.
3.1.4. Confirmatory Factor Analysis (CFA) Results: Fear of COVID-19 Scale (FCV-19S)
To test the model found in EFA, a CFA was performed. The results supported the
EFA findings (Figure 2). A two-factor model was found [χ2(11) = 39.56, p < 0.001] with a
moderate fit for all of the indices [χ2/df ratio = 3.58; CFI = 0.99; TLI = 0.97; SRMR = 0.03;
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RMSEA = 0.07 (0.00, 0.05; 90% CI); PCLOSE = 0.09]. However, to achieve this model, a
correlation between two items’ errors (items 2 and 4) of the first factor and a correlation
between two items’ errors of the second factor (items 3 and 6) were established. As the
items whose errors were correlated belonged to the same factor, in theory, the correlation
is justified. To test if the fear of COVID-19 construct was measured the same way across
genders (women vs. men), multigroup CFAs were performed. The results demonstrated
gender differences, which were evidenced by the model fit [χ2(22) = 44.11, p = 0.03] [χ2/df
ratio = 2.01; CFI = 0.99; TLI = 0.98; SRMR = 0.04; RMSEA = 0.04 (0.00, 0.06; 90% CI);
PCLOSE = 0.74], although the increase in the χ2 value [∆χ2 (5) = 7.93, p < 0.16] between the
models was not significant. Women (M = 2.66; SD = 0.83) presented higher levels of fear of
COVID-19 than men (M = 2.14; SD = 0.79).
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3.1.5. Correlations
CAS correlates positively with FCV-19S (r = 0.53; p < 0.001); with emotional fear
(r = 0.43; p < 0.001); and with cognitive fear (r = 0.57; p < 0.001). CAS correlates positively
with gender (rs = 0.15; p < 0.001); additionally, FCV-19S correlates positively with gender
(rs = 0.26; p < 0.001), as well as emotional fear (rs = 0.29; p < 0.001) and cognitive fear
(rs = 0.18; p < 0.001). No other correlations between CAS and FCV-19S with the selected
sociodemographic variables were found.
Correlations between the seven questions about travel, tourism and hospitality range
from r = 0.19 to r = 0.63, being all the correlations significative at the p < 0.001 level.
Cronbach’s alpha suggests good reliability (Table 3). All questions concerning travel,
tourism and hospitality correlate positively with the CAS and FCV-19S and their dimen-
sions (Table 3). The highest correlations were found between FCV-19S and emotional fear,
on the one hand, and attending hotel facilities, on the other hand. The correlations between
the same dimensions and avoiding settling in a hotel follow. However, if paying attention
to the means of the items related to travel, tourism and hospitality (Table 3), it turns out
that the highest mean relates to the impact of COVID-19 on vacations and leisure time; the
lowest mean refers to traveling by car.
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Table 3. Mean of COVID-related impediments and its Pearson correlations with CAS and FCV-19S.
Instruction: on a Scale of 0 to 100 Please
Indicate How Much the Pandemic Situation
Caused by COVID-19 . . .
M SD CAS FCV-19S Emotional Fear Cognitive Fear
1—changed your leisure activities 71.59 22.49 0.12 0.27 0.29 0.19
2—changed your vacations 72.54 29.79 0.09 0.19 0.20 0.12
3—prevented you from settling in a hotel 49.26 38.97 0.19 0.31 0.32 0.23
4—prevented you from traveling by plane 67.30 39.49 0.10 0.19 0.21 0.11
5—prevented you from traveling by train 47.06 34.83 0.16 0.25 0.26 0.19
6—prevented you from traveling by car 14.39 22.01 0.16 0.21 0.17 0.21
7—made you feel fear of attending hotel facilities 45.22 33.94 0.23 0.42 0.44 0.29
Cronbach’s alpha = 0.80
Notes. M = mean; SD = standard deviation; CAS = Coronavirus Anxiety Scale; FCV-19S = Fear of COVID-19 Scale; all correlations are
significant at the p < 0.001 level.
3.1.6. Regressions
Seeking to find the variables that explained the anxiety related to COVID-19, a
multiple linear regression was performed and explained 7.2% of the anxiety variance
[F(2, 558) = 22.57; p < 0.001], being that the variables gender (β = 0.17; p < 0.000) and use
of hotel equipment (β = 0.20; p < 0.000) contribute significantly to the explanation of this
variance (R2 = 0.07). The same was performed for fear of COVID-19 and it was found that
gender (β = 0.24; p < 0.000), age (β = 0.07; p = 0.050), leisure (β = 0.12; p < 0.000) and use of
hotel equipment (β = 0.37; p < 0.000) contribute significantly to the explanation (R2 = 0.26)
of the fear of COVID-19 variance. Considered together, these variables explain 26% of the
variance of fear of having COVID-19.
4. Discussion
This study aims to determine the anxiety and fear associated with COVID-19 and
their associations with travel, tourism and hospitality, in the Portuguese population. The
study is particularly important because there were no tools to assess these constructs for
the Portuguese population. Accordingly, two instruments to evaluate anxiety and fear in
relation to COVID-19 were assessed and validated. CAS [16] is a five-item scale assessing
distinct physiological reactions of anxiety related to the coronavirus. FCV-19S [10] is
a seven-item scale assessing fear of COVID-19 among the general population. In both
instruments, a high score means more anxiety and more fear, respectively. Both CFAs of
the original one-factor model for CAS and the two-factor model for FCV-19S, proposed
by the authors of the original scale [10,16], showed a good fit with the most important
indices, thus confirming the first stated hypothesis, H1. Additionally, both instruments
revealed good internal consistency for the global score and the two subscales of the FCV-
19S. The findings are consistent with those found for CAS in a significant number of
studies [16–22,24,25,27–29,31–34].
The validated tools were subsequently associated with questions related to travel,
tourism and hospitality. All questions concerning travel, tourism and hospitality correlated
positively with the CAS and FCV-19S and their dimensions, confirming the second hypoth-
esis, H2, and corroborating previous studies [15,40,41]. Participants reported that the items
most impacted by COVID-19 were vacations and leisure time, and the item lesser impacted
was traveling by car, corroborating these results in the literature concerning leisure [42]
and traveling by car [43]. In fact, leisure activities and holidays have undergone profound
changes. However, although care shares have lowered in frequency, people continue to
use their car alone to go to work. The strongest correlation was found between FCV-19S
and emotional fear, on the one hand, and attending hotel facilities, on the other hand.
Interestingly, this correlation with emotional fear suggests that, regardless of the measures
that the hotel industry may be willing to carry out, emotional fear overlaps, which does not
mean that the hotel industry should not continue to invest in hygiene and safety measures
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that guarantee users to regain confidence in such equipment, aiming to overcome resistance
from clients.
These results are just a glimpse of how this pandemic has affected people’s daily lives.
All changes are generating anxiety and fear, especially when they are unwanted, as most
of the changes that people have had to carry out in their life related to COVID-19 [43].
The change process alone causes anxiety. When the reason for the change causes fear,
this overlap of anxiety and fear can be quite disturbing and can have lasting negative
consequences. In fact, fear increases anxiety in healthy individuals and intensifies the
symptoms of those with pre-existing psychiatric disorders.
5. Conclusions
In conclusion, this study provides the CAS and FCV-19S Portuguese versions as
reliable and valid instruments, useful for measuring anxiety and fear related to COVID-19.
The instruments showed good fit indices in the factor structure. The results also show good
consistency indices for global scores and FCV-19S subscales. As far as it is known, these
are the first instruments validated in a Portuguese population which evaluate anxiety and
fear related to COVID-19. This study has some limitations. It is a cross-sectional design
that hinders interpreting causality, and the questionnaire was self-applied. Future studies
should test the fit of the instruments in a clinical sample.
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Appendix A
Fear of COVID-19 Scale
Appendix A.1. English Version
Please indicate your level of agreement with the statements:
Table A1. Items of the Fear of COVID-19 Scale (English version).
Answers Strongly Disagree Disagree Neither Agree nor Disagree Agree Strongly Agree
1. I am most afraid of Corona.     
2. It makes me uncomfortable
to think about Corona.     
3. My hands become clammy
when I think about Corona.     
4. I am afraid of losing my life
because of Corona.     
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Table A1. Cont.
Answers Strongly Disagree Disagree Neither Agree nor Disagree Agree Strongly Agree
5. When watching news and
stories about Corona on social
media, I become nervous or
anxious.
    
6. I cannot sleep because I’m
worrying about getting
Corona.
    
7. My heart races or palpitates
when I think about getting
Corona.
    
Appendix A.2. Portuguese Version
Por favor, assinale a sua concordância ou discordância em relação às seguintes afir-
mações:






1. Tenho muito medo do COVID-19.     
2. Fico desconfortável quando penso
no COVID-19.     
3. As minhas mãos ficam húmidas
quando penso no COVID-19.     
4. Tenho medo de perder a vida por
causa do COVID-19.     
5. Ao assistir às notícias e histórias
sobre o COVID-19 nas redes sociais,
fico nervoso(a) ou ansioso(a).
    
6. Não consigo dormir porque estou
preocupado com a possibilidade de
ficar infetado(a) com COVID-19.
    
7. O meu coração dispara ou palpita
quando penso na possibilidade de
ficar infetado(a) com o COVID-19.
    
Appendix B
Coronavirus Anxiety Scale
Appendix B.1. English Version
How often have you experienced the following activities over the last 2 weeks?
Table A3. Items of the Coronavirus Anxiety Scale (English version).






1. I felt dizzy, lightheaded, or faint, when I
read or listened to news about the
coronavirus.
    
2. I had trouble falling or staying asleep
because I was thinking about the coronavirus.     
3. I felt paralyzed or frozen when I thought
about or was exposed to information about
the coronavirus.
    
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Table A3. Cont.






4. I lost interest in eating when I thought
about or was exposed to information about
the coronavirus.
    
5. I felt nauseous or had stomach problems
when I thought about or was exposed to
information about the coronavirus.
    
Appendix B.2. Portuguese Version
Tendo passado mais de uma hora (no total) por semana a pensar no coronavirus 19 e
a ver notícias nas redes sociais e na televisão sobre ele, por favor indique em quantos dias
teve os seguintes sintomas:









1. Eu sentia-me tonto ou a desmaiar quando
lia ou ouvia notícias sobre a COVID-19.     
2. Tive problemas em adormecer ou manter o
sono porque estava a pensar na COVID-19.     
3. Eu senti-me paralisado(a) ou gelado(a)
quando pensei ou fui exposto(a) a
informações sobre a COVID-19.
    
4. Perdi o interesse em comer quando pensei
ou fui exposto a informações sobre a
COVID-19.
    
5. Senti náuseas ou problemas de estômago
quando pensei ou fui exposto a informações
sobre a COVID-19.
    
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